TIDAL Lumbar Interbody Fusion System ↗
Porous interbody implants for lumbar fusion. [139][133]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Personalized orthopedic implants combining surgical planning, additive manufacturing and a multi-joint reconstruction portfolio.
restor3d develops orthopedic implants and surgical technology using patient-specific planning and additive manufacturing. Its portfolio spans knee, ankle and shoulder reconstruction alongside porous interbody and fusion implants.
The company acquired Conformis in September 2023, expanding its personalized knee-replacement business. Selected FDA records document restor3d-branded TIDAL, Kinos and Veritas systems; those decisions are device-specific and do not establish authorization for every implant or configuration.
Kurt Jacobus leads the company as CEO and chairman. The business combines implant design, manufacturing and surgical support, with commercialization centered on translating personalized anatomy and porous implant structures into usable surgical workflows.
restor3d’s selected commercial implant families have multiple 510(k) decisions, including current Kinos, TIDAL, shoulder and personalized-knee records. The acquired Conformis history is now included, with original applicants preserved. Older Conformis models are not automatically current restor3d products. [139][137][8][15][141][132][1]
The matched FDA history contains 25 distinct recall events: 6 open, 18 terminated, and 1 with another/undetermined closure status. 8 were initiated during the five years beginning October 20, 2021; older open events are also retained. Z-3178-2026 (2026-07-27; open, classified): Ankle implantation systems were packaged with incorrect patient-specific cutting guides, which may result in: delayed surgery, the need to use standard instrumentation, reduced fixation or poor alignment of implants, implant loosening/migration, or need for revision surgery. Z-2987-2026 (2026-06-30; open, classified): Due to incorrect machining of peripheral screw hole resulting in potential for improper engagement of the peripheral screws. Z-1569-2025 (2025-03-25; open, classified): The hip cup liner that was packaged with the incorrect labeling. HDL-060-C22S-000101 from Lot 1788258 contained a hooded liner, but it was labeled to have a standard liner. [125][124][123]
Latest recorded source review: 2026-10-20.
Includes open events outside the mapped current portfolio; those events are excluded from the snapshot count.
| Recalled product / record | Initiated | Source |
|---|---|---|
| July 27, 2026 | [125] |
| June 30, 2026 | [124] |
| March 25, 2025 | [123] |
| March 11, 2024 | [122] |
| June 16, 2023 | [121] |
| November 14, 2022 | [120] |
Documented commercial product families.
Porous interbody implants for lumbar fusion. [139][133]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Total ankle arthroplasty system. [139][134]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Shoulder arthroplasty system documented in a 2026 FDA decision. [139][136]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Reverse total shoulder implant system. [139][135]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Patient-specific knee implants and planning, including the acquired Conformis portfolio. [139]
Marketed · regulatory scope variesCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Expanded personalized knee-replacement portfolio through acquisition. [137]
Accessed 10/29/2026